PMID- 10944171 OWN - NLM STAT- MEDLINE DCOM- 20001107 LR - 20240414 IS - 0022-3751 (Print) IS - 1469-7793 (Electronic) IS - 0022-3751 (Linking) VI - 527 Pt 1 IP - Pt 1 DP - 2000 Aug 15 TI - Store depletion and store-operated Ca2+ current in human prostate cancer LNCaP cells: involvement in apoptosis. PG - 71-83 AB - 1. In the present study, we investigated the mechanisms involved in the induction of apoptosis by the Ca2+-ATPase inhibitor thapsigargin (TG), in androgen-sensitive human prostate cancer LNCaP cells. 2. Exposure of fura-2-loaded LNCaP cells to TG in the presence of extracellular calcium produced an increase in intracellular Ca2+, the first phase of which was associated with depletion of intracellular stores and the second one with consecutive extracellular Ca2+ entry through plasma membrane, store-operated Ca2+ channels (SOCs). 3. For the first time we have identified and characterized the SOC-mediated membrane current (Istore) in prostate cells using whole-cell, cell-attached, and perforated patch-clamp techniques, combined with fura-2 microspectrofluorimetric and Ca2+-imaging measurements. 4. Istore in LNCaP cells lacked voltage-dependent gating and displayed an inwardly rectifying current-voltage relationship. The unitary conductance of SOCs with 80 mM Ca2+ as a charge carrier was estimated at 3.2 +/- 0.4 pS. The channel has a high selectivity for Ca2+ over monovalent cations and is inhibited by Ni2+ (0.5-3 mM) and La3+ (1 microM). 5. Treatment of LNCaP cells with TG (0.1 microM) induced apoptosis as judged from morphological changes. Decreasing extracellular free Ca2+ to 200 nM or adding 0.5 mM Ni2+ enhanced TG-induced apoptosis. 6. The ability of TG to induce apoptosis was not reduced by loading the cells with intracellular Ca2+ chelator (BAPTA-AM). 7. These results indicate that in androgen-sensitive prostate cancer cells the depletion of intracellular Ca2+ stores may trigger apoptosis but that there is no requirement for the activation of store-activated Ca2+ current and sustained Ca2+ entry in induction and development of programmed cell death. FAU - Skryma, R AU - Skryma R AD - Laboratoire de Physiologie Cellulaire, INSERM EPI-9938, Villeneuve d'Ascq, France. FAU - Mariot, P AU - Mariot P FAU - Bourhis, X L AU - Bourhis XL FAU - Coppenolle, F V AU - Coppenolle FV FAU - Shuba, Y AU - Shuba Y FAU - Vanden Abeele, F AU - Vanden Abeele F FAU - Legrand, G AU - Legrand G FAU - Humez, S AU - Humez S FAU - Boilly, B AU - Boilly B FAU - Prevarskaya, N AU - Prevarskaya N LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Physiol JT - The Journal of physiology JID - 0266262 RN - 0 (Androgens) RN - 0 (Calcium Channels) RN - 67526-95-8 (Thapsigargin) RN - 6I3K30563S (Lanthanum) RN - 7OV03QG267 (Nickel) RN - EC 7.2.2.10 (Calcium-Transporting ATPases) RN - SY7Q814VUP (Calcium) SB - IM MH - Androgens/pharmacology MH - *Apoptosis MH - Calcium/metabolism/*physiology MH - Calcium Channels/drug effects/*metabolism MH - Calcium-Transporting ATPases/antagonists & inhibitors MH - Electric Conductivity MH - Humans MH - Lanthanum/pharmacology MH - Male MH - Microscopy, Fluorescence MH - Nickel/pharmacology MH - Patch-Clamp Techniques MH - Prostatic Neoplasms/metabolism/*physiopathology MH - Thapsigargin/pharmacology MH - Tumor Cells, Cultured PMC - PMC2270062 EDAT- 2000/08/16 11:00 MHDA- 2001/02/28 10:01 PMCR- 2001/08/15 CRDT- 2000/08/16 11:00 PHST- 2000/08/16 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/08/16 11:00 [entrez] PHST- 2001/08/15 00:00 [pmc-release] AID - PHY_0641 [pii] AID - 10.1111/j.1469-7793.2000.00071.x [doi] PST - ppublish SO - J Physiol. 2000 Aug 15;527 Pt 1(Pt 1):71-83. doi: 10.1111/j.1469-7793.2000.00071.x.